in Japan and the United States. Microb Drug Resist 9:39-46, 2003
in pediatric patients with community-acquired pneumonia. Antimicrob Agents Chemother 52:348-350, 2008
having mefA and ermB genes that mediate macrolide resistance. J Infect Chemother 9:221-226, 2003
4) Coiras MT, Aguilar JC, Garcia ML, et al:Simultaneous detection of fourteen respiratory viruses in clinical specimens by two multiplex reverse transcription nested-PCR assays. J Med Virol 72:484-495, 2004
5) Espy MJ, Uhl JR, Sloan LM, et al:Real-time PCR in clinical microbiology:applications for routine laboratory testing. Clin Microbiol Rev 19:165-256, 2006
6) Grondahl B, Puppe W, Hoppe A, et al:Rapid identification of nine microorganisms causing acute respiratory tract infections by single-tube multiplex reverse transcription-PCR:feasibility study. J Clin Microbiol 37:1-7, 1999
7) U.S. Food and Drug Administration:cited January 2008. 〈http://www.fda.gov/bbs/topics/NEWS/2008/NEW01770.html〉
8) Hasegawa K, Morozumi M, Nakayam, E, et al:Comprehensive detection of causative pathogens using real-time PCR to diagnose pediatric community-acquired pneumonia. J Infect Chemther (in press)
9) Morozumi M, Nakayama E, Iwata S, et al:Simultaneous detection of pathogens in clinical samples from patients with community-acquired pneumonia by real-time PCR with pathogen-specific molecular beacon probes. J Clin Microbiol 44:1440-1446, 2006
10) Nakayama E, Hasegawa K, Morozumi M, et al:Rapid optimization of antimicrobial chemotherapy given to pediatric patients with commutity-acquired pneumonia using PCR techniques with serology and standard culture. J Infect Chemther 13:305-313, 2007